PUBLIC CONTRACT · 2026
Aquisição de idarucizumab 2.5 g/50 ml sol inj fr 50 ml IV (2026/50 - I1099)
- Contract value
- €4,016.00
- Signed on
- 7 October 2026
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 15744339PUBLISHED SUBJECT
AQUISIÇÃO DE IDARUCIZUMAB 2.5 G/50 ML SOL INJ FR 50 ML IV (2026/50 - I1099)
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- PT1A0 - Grande Lisboa
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- BOERINGER INGLHEIM PORTUGAL · Tax ID 500293023
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €4,016.00
- Procedure base price
- €4,016.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 8 October 2026
- Award date
- 7 October 2026
- Signing date
- 7 October 2026
- Performance period
- 85 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- 2026/50 - Acordo-quadro de medicação antialérgica, vitaminas e sais minerais e medicamentos usados no tratamento de intoxicações
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 11564015
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.